Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma
- PMID: 38342897
- PMCID: PMC10859382
- DOI: 10.1038/s41392-024-01740-4
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, characterized by an intense desmoplastic reaction that compresses blood vessels and limits nutrient supplies. PDAC aggressiveness largely relies on its extraordinary capability to thrive and progress in a challenging tumor microenvironment. Dysregulation of the onco-suppressor miR-15a has been extensively documented in PDAC. Here, we identified the transcription factor Fos-related antigen-2 (Fra-2) as a miR-15a target mediating the adaptive mechanism of PDAC to nutrient deprivation. We report that the IGF1 signaling pathway was enhanced in nutrient deprived PDAC cells and that Fra-2 and IGF1R were significantly overexpressed in miR-15a downmodulated PDAC patients. Mechanistically, we discovered that miR-15a repressed IGF1R expression via Fra-2 targeting. In miR-15a-low context, IGF1R hyperactivated mTOR, modulated the autophagic flux and sustained PDAC growth in nutrient deprivation. In a genetic mouse model, Mir15aKO PDAC showed Fra-2 and Igf1r upregulation and mTOR activation in response to diet restriction. Consistently, nutrient restriction improved the efficacy of IGF1R inhibition in a Fra-2 dependent manner. Overall, our results point to a crucial role of Fra-2 in the cellular stress response due to nutrient restriction typical of pancreatic cancer and support IGF1R as a promising and vulnerable target in miR-15a downmodulated PDAC.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests. C.M.C. is one of the Editors-in-Chief of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.
Figures






Similar articles
-
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.Sci Rep. 2025 Jul 14;15(1):25425. doi: 10.1038/s41598-025-09591-x. Sci Rep. 2025. PMID: 40659704 Free PMC article.
-
TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signaling.Cell Signal. 2025 Oct;134:111949. doi: 10.1016/j.cellsig.2025.111949. Epub 2025 Jun 18. Cell Signal. 2025. PMID: 40553966
-
miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.J Cancer Res Clin Oncol. 2022 Aug;148(8):1903-1918. doi: 10.1007/s00432-022-03951-0. Epub 2022 Apr 27. J Cancer Res Clin Oncol. 2022. PMID: 35476233 Free PMC article.
-
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.J Transl Med. 2025 Jul 4;23(1):744. doi: 10.1186/s12967-025-06778-8. J Transl Med. 2025. PMID: 40616159 Free PMC article. Review.
-
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.Eur J Cancer. 2015 Jul;51(11):1389-404. doi: 10.1016/j.ejca.2015.04.006. Epub 2015 May 19. Eur J Cancer. 2015. PMID: 26002251
Cited by
-
Death-ision: the link between cellular resilience and cancer resistance to treatments.Mol Cancer. 2025 May 15;24(1):144. doi: 10.1186/s12943-025-02339-1. Mol Cancer. 2025. PMID: 40375296 Free PMC article. Review.
-
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.Cancers (Basel). 2024 Jun 27;16(13):2364. doi: 10.3390/cancers16132364. Cancers (Basel). 2024. PMID: 39001427 Free PMC article. Review.
-
circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).Mol Cancer. 2024 May 7;23(1):91. doi: 10.1186/s12943-024-01998-w. Mol Cancer. 2024. PMID: 38715012 Free PMC article.
-
Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges.Curr Oncol Rep. 2025 Mar;27(3):195-210. doi: 10.1007/s11912-025-01635-9. Epub 2025 Feb 6. Curr Oncol Rep. 2025. PMID: 39913071 Review.
-
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation.J Exp Clin Cancer Res. 2025 Mar 14;44(1):96. doi: 10.1186/s13046-025-03354-2. J Exp Clin Cancer Res. 2025. PMID: 40082972 Free PMC article.
References
-
- Kalli M, Li R, Mills GB, Stylianopoulos T, Zervantonakis IK. Mechanical stress signaling in pancreatic cancer cells triggers p38 MAPK- and JNK-dependent cytoskeleton remodeling and promotes cell migration via Rac1/cdc42/Myosin II. Mol. Cancer Res. 2022;20:485–497. doi: 10.1158/1541-7786.MCR-21-0266. - DOI - PMC - PubMed
-
- Perera RM, Bardeesy N. Pancreatic cancer metabolism - breaking it down to build it back up. Cancer Discov. 2015;5:1247–1261. doi: 10.1158/2159-8290.CD-15-0671. - DOI - PMC - PubMed
-
- McAndrews KM, et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer. Cancer Discov. 2022;12:1580–1597. doi: 10.1158/2159-8290.CD-20-1484. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous